Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Begoña Mellado
Nivolumab Alone and With Ipilimumab in Previously Treated Metastatic Urothelial Carcinoma: CheckMate 032 Nivolumab 1 Mg/Kg Plus Ipilimumab 3 Mg/Kg Expansion Cohort Results
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Related publications
Nivolumab Monotherapy and Nivolumab Plus Ipilimumab in Recurrent Small Cell Lung Cancer: Results From the CheckMate 032 Randomized Cohort
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Safety of Nivolumab Plus Low‐Dose Ipilimumab in Previously Treated Microsatellite Instability‐High/Mismatch Repair‐Deficient Metastatic Colorectal Cancer
Oncologist
Cancer Research
Medicine
Oncology
Pcn184 - Cost-Effectiveness of Nivolumab Plus Ipilimumab in Advanced Melanoma
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
P1.01-02 Long-Term Outcomes With First-Line Nivolumab Plus Ipilimumab in Advanced NSCLC: 3-Year Follow-Up From CheckMate 012
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Severe Hemophagocytic Lymphohistiocytosis in a Melanoma Patient Treated With Ipilimumab + Nivolumab
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
Nivolumab Plus Ipilimumab Achieves Responses in dMMR/MSI-H Tumors
Cancer Discovery
Oncology
P2.16-03 CheckMate 816: A Phase 3 Trial of Neoadjuvant Nivolumab Plus Ipilimumab or Chemotherapy vs Chemotherapy in Early-Stage NSCLC
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Patterns of Response in Patients With Pretreated Metastatic Melanoma Who Received Ipilimumab 3 Mg/Kg in a European Expanded Access Program: Five Illustrative Case Reports
Cancer Investigation
Medicine
Cancer Research
Oncology
E3611- A Randomized Phase II Study of Ipilimumab at 3 or 10 Mg/Kg Alone or in Combination With High Dose Interferon-Α2b in Advanced Melanoma
Clinical Cancer Research
Cancer Research
Oncology
